Preferred Label : mupirocin;
MeSH definition : A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown
excellent activity against gram-positive staphylococci and streptococci. The antibiotic
is used primarily for the treatment of primary and secondary skin disorders, nasal
infections, and wound healing.;
MeSH synonym : pseudomonic acid a;
CISMeF synonym : acid, pseudomonic; pseudomonic acid;
MeSH hyponym : Mupirocin, Calcium Salt (2:1); Mupirocin, Calcium Salt (2:1), Dihydrate; mupirocin, 14C-Labeled; mupirocin, sodium salt; BRL-4910A; mupirocin, lithium salt; bactroban; BRL 4910A; BRL4910A; 14C-Labeled Mupirocin; Mupirocin, 14C Labeled;
MeSH CAS label : nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-,
(2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-;
MeSH Related Number : mupirocin, 14C-Labeled; mupirocin, sodium salt; mupirocin, calcium salt (2:1), dihydrate; mupirocin, lithium salt; mupirocin, calcium salt (2:1); 104486-81-9 (Ca(2:1) salt(2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); 115074-43-6 (Ca(2:1) dihydrate salt (2S-(2alpha(E),3beta,5alpha(2R*,3R*(1R*,2R*))))); 12650-69-0 (Mupirocin); 64838-37-5 (Na salt); 73346-79-9 (Li salt(2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); 85617-79-4 (2-(14C-labeled(2S-2alpha(e),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))); RG38I2P540;
Registry Number MeSH : 12650-69-0;
Related CAS MeSH : 85617-79-4 (Mupirocin, 14C-Labeled); 64838-37-5 (Mupirocin, sodium salt); 115074-43-6 (Mupirocin, calcium salt (2:1), dihydrate); 73346-79-9 (Mupirocin, lithium salt); 104486-81-9 (Mupirocin, calcium salt (2:1));
Wikipedia link : https://en.wikipedia.org/wiki/Mupirocin;
Is substance : O;
UNII : D0GX863OA5;
InChIKey : MINDHVHHQZYEEK-HBBNESRFSA-N;
Origin ID : D016712;
UMLS CUI : C0085259;
ATC code(s)
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown
excellent activity against gram-positive staphylococci and streptococci. The antibiotic
is used primarily for the treatment of primary and secondary skin disorders, nasal
infections, and wound healing.
https://www.has-sante.fr/portail/jcms/c_2894929/en/mupiderm
2018
true
France
French
antibiotic therapy
mupirocin
administration, cutaneous
anti-bacterial agents
insurance, health, reimbursement
mupirocin
impetigo
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2752329/fr/bactroban
2017
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
mupirocin
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68172597
2016
false
false
false
France
French
summary of product characteristics
package leaflet
administration, cutaneous
drugs, generic
mupirocin
mupirocin
ointments
skin diseases, bacterial
staphylococcal skin infections
streptococcal infections
anti-bacterial agents
---
http://unt-ori2.crihan.fr/unspf/2014_Rennes_Tomasi_Antibacteriens-divers
2015
false
true
true
France
French
educational course
fosfomycin
mupirocin
education, pharmacy
mupirocin
mupirocin
mupirocin
fosfomycin
fosfomycin
fosfomycin
fusidic acid
fusidic acid
fusidic acid
fusidic acid
fusidic acid
anti-bacterial agents
---
http://www.has-sante.fr/portail/jcms/c_1768786/fr/mupiderm
http://www.has-sante.fr/portail/jcms/c_722943/mupiderm
2014
false
France
French
antibiotic therapy
mupirocin
administration, cutaneous
anti-bacterial agents
insurance, health, reimbursement
mupirocin
impetigo
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1221576/bactroban
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/bactroban_15022012_avis_ct11658.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_459735
2012
France
French
secondary prevention
antibiotic therapy
mupirocin
anti-bacterial agents
ointments
administration, intranasal
insurance, health, reimbursement
staphylococcus aureus
staphylococcal skin infections
staphylococcal infections
adult
child
treatment outcome
renal dialysis
mupirocin
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD006216
2011
United Kingdom
France
French
antibiotic therapy
french abstract
meta-analysis
staphylococcus aureus
staphylococcal infections
treatment outcome
carrier state
ointments
mupirocin
anti-bacterial agents
nose
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66325311
2008
France
French
antibiotic therapy
anti-bacterial agents
protein synthesis inhibitors
administration, intranasal
ointments
mupirocin
mupirocin
anti-bacterial agents
drug approval
drug labeling
staphylococcal skin infections
staphylococcus aureus
staphylococcal infections
adult
child
protein synthesis inhibitors
mupirocin
summary of product characteristics
package leaflet
---